Comparison of Treatment Persistence with Dabigatran or Rivaroxaban versus Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients: A Competing Risk Analysis in the French National Health Care Databases. [electronic resource]
Producer: 20181211Description: 6-18 p. digitalISSN:- 1875-9114
- Administration, Oral
- Age Factors
- Aged
- Aged, 80 and over
- Anticoagulants -- administration & dosage
- Atrial Fibrillation -- complications
- Cohort Studies
- Dabigatran -- administration & dosage
- Databases, Factual
- Dose-Response Relationship, Drug
- Female
- France
- Hemorrhage -- chemically induced
- Hospitalization -- statistics & numerical data
- Humans
- International Normalized Ratio
- Male
- Middle Aged
- Rivaroxaban -- administration & dosage
- Stroke -- prevention & control
- Vitamin K -- antagonists & inhibitors
- Assessment of Medication Adherence
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.